B5.001 Big Case Flashcards

1
Q

what is acanthosis nigricans

A

velvety, hyperpigmented plaques on the skin
commonly on neck and axilla
non-irritable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

pathophys of acanthosis nigricans

A

elevated levels of insulin may stimulate keratinocyte and dermal fibroblast proliferation via interaction with IGFR1
result in plaque like lesions
associated with multiple disorders characterized by insulin resistance/hyperinsulinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are screening recommendations for diabetes in asymptomatic persons

A

begin at 45 years of age, every 3 years

screen at any age and more frequently if BMI is >25 or person has additional risk factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ADA sanctioned risk factors for diabetes

A
family history
high risk race
HbA1c >5.7% or impaired glucose levels on previous testing
polycystic ovary syndrome
HTN
HDL < 35, TG > 250
CVD history
physical inactivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is IFG and how does it manifest

A

impaired fasting glucose (baseline too high)

fasting plasma glucose 100-125

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is IGT and how does it manifest

A

impaired glucose tolerance (doesn’t return to baseline very easily)
2 hour post prandial glucose 140-199

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

test values for normal glucose metabolism

A

HbA1c <5.7
fasting glucose < 100
OGTT <140

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

test values for type 2 diabetes

A

HbA1c <6.5
fasting glucose >126
OGTT >200

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

best way to reduce the incidence of DM2

A

lifestyle intervention (exercise and dietary restrictions)
reduced incidence more than metformin alone or placebo
58% vs 31% reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

3 primary components leading to pre-diabetes and/or DM2

A

`insulin resistance
relative insulin deficiency
impaired incretin action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how does insulin level change over the natural course of DM2

A

initially very high levels

at onset of diabetes, begins to decrease to below normal levels and continue to decrease over time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how is obesity implicate din the development of DM2

A

abdominal adipose more metabolically active than subcutaneous fat
increased release of FFA, TNFa and other hormones can lead to increased insulin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is central obesity

A

waist to hip ratio >1
waist > 40 in in med
waist > 35 in in women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

definition of metabolic syndrome

A
any 3 of the following:
abdominal obesity
TG > 150
HDL <40 for men, <50 for women
BP >135/85
fasting glucose >100
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

normal function of insulin

A

inhibit lipolysis
inhibit glucose production
stimulate glucose uptake by muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what portions of the brain is insulin thought to act on

A

hypothalamus

prefrontal cortec

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

discuss the reduction of B cells in DM2

A

the human pancreas is incapable of renewing B cells after age 30
glucolipotoxicity and amyloid deposition result in B cell apoptosis through oxidative and endoplasmic reticulum stress

18
Q

discuss the role of a cell dysfunction in DM1

A

abnormal glucagon release
elevated fasting glucagon (increases glucose production from hepatocytes and contributes to hyperglycemia)
non-suppression after meal ingestion

19
Q

what is the incretin effect?

A

oral glucose provides a much greater C-peptide response than IV glucose

20
Q

what is C-peptide

A

measure of innate insulin production

only created by the body and longer lasting than insulin

21
Q

what is incretin

A

substance released by the gut in response to food that stimulates insulin secretion

22
Q

two well described incretins

A

glucagon-like peptide-1 (GLP-1)

glucose-dependent insulinotropic peptide (GIP) (minor, not as potent and GLP-1)

23
Q

discuss the role of the GI tract in hormonal dysfunction in DM2

A

meal stimulated levels of GLP-1 are reduced
deficient GLP-1 response contributes to a rise in plasma glucagon secretion and impaired suppression of hepatic glucose production after a meal
deficient GLP-1 response leads to reduction in insulin secretion

24
Q

discuss the role of the a cell in hormonal dysfunction in DM2

A

elevated basal glucagon leads to increased rate of hepatic glucose production
possible liver hypersensitivity to stimulatory effect of glucagon in hepatic gluconeogenesis

25
fasting state function of normal liver
increased HGP
26
fed state function of normal liver
decreased HGP
27
discuss the role of the liver in hormonal dysfunction in DM2
failure of insulin to suppress glucagon secretion increased glucagon leads to elevated basal hepatic glucose production despite hyperinsulinemia enhanced hepatic sensitivity to glucagon
28
effects of GLP-1 on liver, a cells, stomach, B cells, and CNS
``` liver: less glucagon = less HGP a cell: decreases post prandial glucagon stomach: slows gastric emptying B cell: increases insulin CNS: promotes satiety and reduction of appetite ```
29
which enzyme degrades GLP-1 and at what pace
DDP2 | half life = 60-90 s
30
what is the role of DDP4
ubiquitous serine protease high levels in lumen of intestine, liver, lung, and kidney multiple substrates including GLP-1 and GIP expressed on surface of T cells to play a role in activation and immunological responses
31
effects of blood sugar alterations on macrocirculation
atherosclerosis | coronary, peripheral, and cerebral arteries
32
effects of blood sugar alterations on microcirculation
affects BM of small blood vessels and capillaries | eyes and kidneys
33
discuss the risk of CVD in diabetic pts
major source of mortality 2/3 of diabetics die of heart disease or stroke increased risk of MI and CHF
34
discuss diabetic nephropathy
glomerulosclerosis first indicator is microalbuminuria DM1 - evidence after 10-15 y with uncontrolled disease DM2- evidence sooner since may have gone years without diagnosis
35
discuss diabetic retinopathy
``` major cause of blindness in adults 20-74 affects almost all DM1 after 20 years affects 60% of DM2 patients progressive, irreversible vision loss hemorrhages on the retina of an eye ```
36
non-proliferative diabetic retinopathy vs proliferative
both due to hyperglycemia difference - VEGF expression proliferative has upregulated VEGF and growth of abnormal blood vessels non-proliferative has aneurysms, hemorrhage, and exudate in existing vessels
37
sensory motor (peripheral) neuropathy
``` paresthesias primarily in lower extremities decreased deep tendon reflexes numb feet decreased proprioception decreased sensation unsteady gait increased risk of foot injury ```
38
autonomic neuropathy
not as common | can affect almost any system
39
what is hypoglycemic unawareness
lack of autonomic response to recognize/correct hypoglycemia | results from an autonomic dysfunction of adrenal glands
40
best treatment for diabetic neuropathy
prevention with glycemic control
41
misc complications associated with DM
increased susceptibility to infection periodontal disease foot ulcers and infections
42
what 2 major complications increase risk of foot infections
1. neuropathy decreases sensation and increases dryness and fissures 2. peripheral vascular disease decreases circulation which contributes to poor wound healing and susceptibility to antibiotics leading to gangrene